Machine learning used to generate AAV capsids for gene therapy
A study has used artificial intelligence to reveal adeno-associated virus (AAV) capsid variants for use in gene therapies.
List view / Grid view
A study has used artificial intelligence to reveal adeno-associated virus (AAV) capsid variants for use in gene therapies.
In this ebook, we’ll see how digitally enabling your organisation can increase capacity and improve vaccine production.
Researchers have developed a personalised medicine platform that could advance genomic medicine research for cancer.
In this whitepaper we explore some of the major bottlenecks in the development lifecycle and the current barriers to effective digital transformation.
Discover how workflows are being accelerated to speed up the vaccine research and development process while maintaining safety and immunogenicity.
In this article, Ramya Sriram describes how data science is driving innovations in medical biotechnology and genomics.
Computational drug screening has shown that chemotherapy drug pralatrexate could potentially be repurposed to treat COVID-19.
Dr Isaac Karimi and his team explain how compounds to treat COVID-19 could be found in Kurdish ethnomedicine, selecting some plants for computational drug discovery.
Scientists have created a drug discovery platform that enables the discovery and optimisation of RNA-targeting compounds.
Scientists have trained a computer algorithm to identify differences in cancer cell lines based on microscopic images, preventing the misclassification of cells.
Dr Diogo Camacho from the Wyss Institute at Harvard discusses new research into using machine learning algorithms to analyse RNA sequences and reveal potential drug targets.
An artificial intelligence (AI) system called AlphaFold has been developed to effectively predict protein structures and folding.
A model of a human lung cell has been used to understand how SARS-CoV-2 uses host cell processes to reproduce, revealing drug targets.
The tool uses interactive molecular dynamics simulations in virtual reality (iMD-VR) to allow researchers to step inside SARS-CoV-2 enzymes and visualise molecules binding to them.
A major challenge within electrophysiology labs is 50 or 60 Hz line frequency electrical noise, which can either distort or completely drown out biological signal.